Brief: Adaptive Biotechnologies Q4 EPS USD -0.48
14/02/2024 21:06
Feb 14 (Reuters) - Adaptive Biotechnologies Q4 revenue USD 45.784 million vs. IBES estimate USD 48.5 million. * Q4 operating expenses USD 116.852 million * Q4 operating income USD -71.068 million vs. IBES estimate USD -36.7 million * Q4 net income USD -69.467 million vs. IBES estimate USD -38.8 million * Q4 adjusted EBITDA USD -24.7 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates